SBS - Short Bowel Syndrome Clinical Trial
Official title:
Development and Validation of a Questionnaire to Measure the Impact of Short Bowel Syndrome (SBS) and Its Treatments on Patients' Lives
Today, patients express a very strong need to take into account the consequences of their
disease and its treatments in their therapeutic follow-up. It is therefore essential to
better understand the needs, expectations and values of patients with SBS in order to better
understand the impact of the disease on their lives, and thus improve the conditions for
medical, social, psychological and technical care. The clinical expertise of health
professionals and meetings with patient associations demonstrate the major gap between the
parameters taken into account by physician to evaluate the evolution of the SBS and the
day-to-day experience of the disease perceived by the patient.
The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the
impact of SBS and its treatments on daily life from the perspective of patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03408132 -
Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
|
Phase 1/Phase 2 |